A 3-way, double-blind, randomized, crossover trial to evaluate effects of nebivolol and valsartan alone and in combination on 24-hour ambulatory rate-pressure product, stroke load, and blood pressure-heart rate variability in patients with hypertension.

Trial Profile

A 3-way, double-blind, randomized, crossover trial to evaluate effects of nebivolol and valsartan alone and in combination on 24-hour ambulatory rate-pressure product, stroke load, and blood pressure-heart rate variability in patients with hypertension.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Jun 2015

At a glance

  • Drugs Nebivolol (Primary) ; Valsartan (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Jun 2015 Results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top